China NMPA Product Recall - Soft contact lenses (brand name: Hydrogel contact lenses)

On March 19, 2019, Johnson & Johnson Vision Care Trading (Shanghai) Co., Ltd. announced a voluntary Class II recall of its Ambilight Hydrogel brand soft contact lenses. This significant action, reported to the National Medical Products Administration (NMPA) and the Shanghai Food and Drug Administration, stems from critical quality issues identified in specific batch numbers. These issues include observable manufacturing defects such as cracks, the presence of holes or bubbles within the lenses, and subsequent reports from users experiencing occasional discomfort after wearing the product. The company's decision to initiate this recall underscores its commitment to patient safety and compliance with the regulatory framework governing medical devices in China. A Class II recall indicates that the use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. Further detailed information regarding the specific product models, specifications, and affected batches was made available through the 'Medical Device Recall Event Report Form.' This proactive measure ensures that potentially non-compliant products are effectively removed from circulation, upholding public health standards and regulatory expectations set by authorities like the NMPA.